Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ctxR: Utilities for interacting with the CTX APIs.

NAM journal·2026
Same author

Unraveling the nexus: Tumor mutational burden, PD-L1 expression, and oncogenic alterations in non-small cell lung cancer cytology specimens.

Cancer cytopathology·2026
Same author

Growth Hormone Pathway as a Prognostic and Therapeutic Biomarker in Patients With Unresectable Hepatocellular Carcinoma Treated With Radiation Therapy.

Advances in radiation oncology·2026
Same author

Generation of CCR4/CD7 Bispecific CAR-T Cells Resistant to Fratricide and Exhaustion.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma.

Journal of hepatocellular carcinoma·2025
Same author

Chimeric antigen receptor-based cellular therapy for T-cell malignancies.

Critical reviews in oncology/hematology·2025
Same journal

TRPS1 and GATA3 Expression in BRG1/SMARCA4-deficient Malignant Neoplasms.

Human pathology·2026
Same journal

Clinicopathologic and Molecular Characteristics of Acral Melanomas Harboring RARA Fusions.

Human pathology·2026
Same journal

Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

Human pathology·2026
Same journal

Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

Human pathology·2026
Same journal

Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

Human pathology·2026
Same journal

Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

Human pathology·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.0K

Molecular characterization of gallbladder cancer using somatic mutation profiling.

Milind Javle1, Asif Rashid1, Chaitanya Churi1

  • 1The University of Texas M.D. Anderson Cancer Center, Houston, TX,77054, USA.

Human Pathology
|February 11, 2014
PubMed
Summary
This summary is machine-generated.

Molecular profiling of gallbladder cancer (GBC) identified targetable mutations, including KRAS, which correlated with poor survival. Next-generation sequencing (NGS) is a feasible approach for discovering novel mutations for advanced GBC targeted therapies.

Keywords:
DNA sequencingGallbladder neoplasmsMutational analysis

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.6K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K

Related Experiment Videos

Last Updated: May 3, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.0K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.6K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gallbladder cancer (GBC) is uncommon globally but has high incidence in specific regions.
  • Limited molecular characterization hinders targeted therapy development for advanced GBC.

Purpose of the Study:

  • To investigate targetable somatic mutations in gallbladder cancer using archival samples.
  • To assess the feasibility of molecular profiling for identifying therapeutic targets.

Main Methods:

  • Surgical pathology from 72 GBC cases (formalin-fixed, paraffin-embedded) were analyzed.
  • Two methods were employed: mass spectroscopy for 159 hotspot mutations in 33 genes, and next-generation sequencing (NGS) for 182 cancer-related genes.
  • Fifty-seven cases underwent hotspot mutation analysis, and 15 underwent NGS.

Main Results:

  • Fourteen hotspot mutations were found in 9 cases; KRAS mutations were linked to poorer survival.
  • NGS identified 26 mutations in 15 cases, with common TP53 and PI3 kinase pathway alterations.
  • Novel findings included FGF10 amplification and an FGF3-TACC gene fusion in GBC.

Conclusions:

  • Somatic mutation profiling of GBC using archival FFPE samples is achievable.
  • NGS is a valuable tool for identifying novel mutations and potential targeted therapies in GBC.
  • Further research into these mutations may lead to improved GBC treatment strategies.